Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body.
This report aims to provide a comprehensive presentation of the global market for Transplantation Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transplantation Therapeutics Drugs. This report contains market size and forecasts of Transplantation Therapeutics Drugs in global, including the following market information:
Global Transplantation Therapeutics Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Transplantation Therapeutics Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Calcineurin Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transplantation Therapeutics Drugs include Novartis, GlaxoSmithKline, AbbVie, Pfizer, Astellas Pharma, Gilead Sciences, SBI Biotech, Sanofi and Takeda, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transplantation Therapeutics Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transplantation Therapeutics Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Transplantation Therapeutics Drugs Market Segment Percentages, by Type, 2022 (%)
Calcineurin Inhibitors
Anti-Proliferative Agents
Corticosteroids
Others
Global Transplantation Therapeutics Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Transplantation Therapeutics Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Transplantation Therapeutics Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Transplantation Therapeutics Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transplantation Therapeutics Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Transplantation Therapeutics Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
GlaxoSmithKline
AbbVie
Pfizer
Astellas Pharma
Gilead Sciences
SBI Biotech
Sanofi
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transplantation Therapeutics Drugs, market overview.
Chapter 2: Global Transplantation Therapeutics Drugs market size in revenue.
Chapter 3: Detailed analysis of Transplantation Therapeutics Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transplantation Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Transplantation Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transplantation Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transplantation Therapeutics Drugs Overall Market Size
2.1 Global Transplantation Therapeutics Drugs Market Size: 2022 VS 2030
2.2 Global Transplantation Therapeutics Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transplantation Therapeutics Drugs Players in Global Market
3.2 Top Global Transplantation Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Transplantation Therapeutics Drugs Revenue by Companies
3.4 Top 3 and Top 5 Transplantation Therapeutics Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Transplantation Therapeutics Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transplantation Therapeutics Drugs Players in Global Market
3.6.1 List of Global Tier 1 Transplantation Therapeutics Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Transplantation Therapeutics Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Transplantation Therapeutics Drugs Market Size Markets, 2022 & 2030
4.1.2 Calcineurin Inhibitors
4.1.3 Anti-Proliferative Agents
4.1.4 Corticosteroids
4.1.5 Others
4.2 By Type - Global Transplantation Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Transplantation Therapeutics Drugs Revenue, 2018-2023
4.2.2 By Type - Global Transplantation Therapeutics Drugs Revenue, 2024-2030
4.2.3 By Type - Global Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transplantation Therapeutics Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Transplantation Therapeutics Drugs Revenue & Forecasts
5.2.1 By Application - Global Transplantation Therapeutics Drugs Revenue, 2018-2023
5.2.2 By Application - Global Transplantation Therapeutics Drugs Revenue, 2024-2030
5.2.3 By Application - Global Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Transplantation Therapeutics Drugs Market Size, 2022 & 2030
6.2 By Region - Global Transplantation Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Transplantation Therapeutics Drugs Revenue, 2018-2023
6.2.2 By Region - Global Transplantation Therapeutics Drugs Revenue, 2024-2030
6.2.3 By Region - Global Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Transplantation Therapeutics Drugs Revenue, 2018-2030
6.3.2 US Transplantation Therapeutics Drugs Market Size, 2018-2030
6.3.3 Canada Transplantation Therapeutics Drugs Market Size, 2018-2030
6.3.4 Mexico Transplantation Therapeutics Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Transplantation Therapeutics Drugs Revenue, 2018-2030
6.4.2 Germany Transplantation Therapeutics Drugs Market Size, 2018-2030
6.4.3 France Transplantation Therapeutics Drugs Market Size, 2018-2030
6.4.4 U.K. Transplantation Therapeutics Drugs Market Size, 2018-2030
6.4.5 Italy Transplantation Therapeutics Drugs Market Size, 2018-2030
6.4.6 Russia Transplantation Therapeutics Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Transplantation Therapeutics Drugs Market Size, 2018-2030
6.4.8 Benelux Transplantation Therapeutics Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Transplantation Therapeutics Drugs Revenue, 2018-2030
6.5.2 China Transplantation Therapeutics Drugs Market Size, 2018-2030
6.5.3 Japan Transplantation Therapeutics Drugs Market Size, 2018-2030
6.5.4 South Korea Transplantation Therapeutics Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Transplantation Therapeutics Drugs Market Size, 2018-2030
6.5.6 India Transplantation Therapeutics Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Transplantation Therapeutics Drugs Revenue, 2018-2030
6.6.2 Brazil Transplantation Therapeutics Drugs Market Size, 2018-2030
6.6.3 Argentina Transplantation Therapeutics Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transplantation Therapeutics Drugs Revenue, 2018-2030
6.7.2 Turkey Transplantation Therapeutics Drugs Market Size, 2018-2030
6.7.3 Israel Transplantation Therapeutics Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Transplantation Therapeutics Drugs Market Size, 2018-2030
6.7.5 UAE Transplantation Therapeutics Drugs Market Size, 2018-2030
7 Transplantation Therapeutics Drugs Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Transplantation Therapeutics Drugs Major Product Offerings
7.1.4 Novartis Transplantation Therapeutics Drugs Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Transplantation Therapeutics Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Transplantation Therapeutics Drugs Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Transplantation Therapeutics Drugs Major Product Offerings
7.3.4 AbbVie Transplantation Therapeutics Drugs Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Transplantation Therapeutics Drugs Major Product Offerings
7.4.4 Pfizer Transplantation Therapeutics Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Astellas Pharma
7.5.1 Astellas Pharma Company Summary
7.5.2 Astellas Pharma Business Overview
7.5.3 Astellas Pharma Transplantation Therapeutics Drugs Major Product Offerings
7.5.4 Astellas Pharma Transplantation Therapeutics Drugs Revenue in Global Market (2018-2023)
7.5.5 Astellas Pharma Key News & Latest Developments
7.6 Gilead Sciences
7.6.1 Gilead Sciences Company Summary
7.6.2 Gilead Sciences Business Overview
7.6.3 Gilead Sciences Transplantation Therapeutics Drugs Major Product Offerings
7.6.4 Gilead Sciences Transplantation Therapeutics Drugs Revenue in Global Market (2018-2023)
7.6.5 Gilead Sciences Key News & Latest Developments
7.7 SBI Biotech
7.7.1 SBI Biotech Company Summary
7.7.2 SBI Biotech Business Overview
7.7.3 SBI Biotech Transplantation Therapeutics Drugs Major Product Offerings
7.7.4 SBI Biotech Transplantation Therapeutics Drugs Revenue in Global Market (2018-2023)
7.7.5 SBI Biotech Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Transplantation Therapeutics Drugs Major Product Offerings
7.8.4 Sanofi Transplantation Therapeutics Drugs Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Transplantation Therapeutics Drugs Major Product Offerings
7.9.4 Takeda Transplantation Therapeutics Drugs Revenue in Global Market (2018-2023)
7.9.5 Takeda Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Transplantation Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 2. Transplantation Therapeutics Drugs Market Drivers in Global Market
Table 3. Transplantation Therapeutics Drugs Market Restraints in Global Market
Table 4. Key Players of Transplantation Therapeutics Drugs in Global Market
Table 5. Top Transplantation Therapeutics Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Transplantation Therapeutics Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Transplantation Therapeutics Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Transplantation Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Transplantation Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transplantation Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Transplantation Therapeutics Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Transplantation Therapeutics Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Transplantation Therapeutics Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Transplantation Therapeutics Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Transplantation Therapeutics Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Transplantation Therapeutics Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Novartis Company Summary
Table 31. Novartis Transplantation Therapeutics Drugs Product Offerings
Table 32. Novartis Transplantation Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Transplantation Therapeutics Drugs Product Offerings
Table 36. GlaxoSmithKline Transplantation Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. AbbVie Company Summary
Table 39. AbbVie Transplantation Therapeutics Drugs Product Offerings
Table 40. AbbVie Transplantation Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. AbbVie Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Transplantation Therapeutics Drugs Product Offerings
Table 44. Pfizer Transplantation Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Astellas Pharma Company Summary
Table 47. Astellas Pharma Transplantation Therapeutics Drugs Product Offerings
Table 48. Astellas Pharma Transplantation Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Astellas Pharma Key News & Latest Developments
Table 50. Gilead Sciences Company Summary
Table 51. Gilead Sciences Transplantation Therapeutics Drugs Product Offerings
Table 52. Gilead Sciences Transplantation Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Gilead Sciences Key News & Latest Developments
Table 54. SBI Biotech Company Summary
Table 55. SBI Biotech Transplantation Therapeutics Drugs Product Offerings
Table 56. SBI Biotech Transplantation Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. SBI Biotech Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Transplantation Therapeutics Drugs Product Offerings
Table 60. Sanofi Transplantation Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Takeda Company Summary
Table 63. Takeda Transplantation Therapeutics Drugs Product Offerings
Table 64. Takeda Transplantation Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Takeda Key News & Latest Developments
List of Figures
Figure 1. Transplantation Therapeutics Drugs Segment by Type in 2022
Figure 2. Transplantation Therapeutics Drugs Segment by Application in 2022
Figure 3. Global Transplantation Therapeutics Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transplantation Therapeutics Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Transplantation Therapeutics Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transplantation Therapeutics Drugs Revenue in 2022
Figure 8. By Type - Global Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 16. US Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 28. China Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Transplantation Therapeutics Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Novartis Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AbbVie Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Astellas Pharma Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gilead Sciences Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. SBI Biotech Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Takeda Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
